Mycobacterium marinum Infection

Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 719)

Abstract

Mycobacterium marinum was first identified as a causative organism of tuberculosis in fish in 1926 [1], but its pathogenic role in causing skin disease in humans was only identified more than two decades later [2]. The organism is prevalent in natural aquatic environments world-wide and can be found in fresh, brackish and salt water [3].

Keywords

Cutaneous Leishmaniasis Pyoderma Gangrenosum Nontuberculous Mycobacterium Publish Case Series Natural Aquatic Environment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Aronson JD. Spontaneous tuberculosis in salt water fish. J Inf Dis 1926;39(4):315–20.CrossRefGoogle Scholar
  2. 2.
    Norden A, Linell F. A new type of pathogenic Mycobacterium. Nature 1951;168(4280):826.PubMedCrossRefGoogle Scholar
  3. 3.
    Petrini B. Mycobacterium marinum: ubiquitous agent of waterborne granulomatous skin infections. Eur J Clin Microbiol Infect Dis 2006;25(10):609–13.PubMedCrossRefGoogle Scholar
  4. 4.
    Ramakrishnan L, Valdivia RH, McKerrow JH, Falkow S. Mycobacterium marinum causes both long-term ­subclinical infection and acute disease in the leopard frog (Rana pipiens). Infect Immun 1997;65(2):767–73.PubMedGoogle Scholar
  5. 5.
    Kaattari IM, Rhodes MW, Kaattari SL, Shotts EB. The evolving story of Mycobacterium tuberculosis clade ­members detected in fish. J Fish Dis 2006;29(9):509–20.PubMedCrossRefGoogle Scholar
  6. 6.
    Sato T, Shibuya H, Ohba S, Nojiri T, Shirai W. Mycobacteriosis in two captive Florida manatees (Trichechus manatus latirostris). J Zoo Wildl Med 2003;34(2):184–8.PubMedGoogle Scholar
  7. 7.
    Cosma CL, Swaim LE, Volkman H, Ramakrishnan L, Davis JM. Zebrafish and frog models of Mycobacterium marinum infection. Curr Protoc Microbiol 2006;Chapter 10:Unit 10B 2.Google Scholar
  8. 8.
    Swaim LE, Connolly LE, Volkman HE, Humbert O, Born DE, Ramakrishnan L. Mycobacterium marinum ­infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity. Infect Immun 2006;74(11):6108–17.PubMedCrossRefGoogle Scholar
  9. 9.
    Gauthier DT, Rhodes MW. Mycobacteriosis in fishes: a review. Vet J 2009;180(1):33–47.PubMedCrossRefGoogle Scholar
  10. 10.
    Ho MH, Ho CK, Chong LY. Atypical mycobacterial cutaneous infections in Hong Kong: 10-year retrospective study. Hong Kong Med J 2006;12(1):21–6.PubMedGoogle Scholar
  11. 11.
    Kullavanijaya P, Sirimachan S, Bhuddhavudhikrai P. Mycobacterium marinum cutaneous infections acquired from occupations and hobbies. Int J Dermatol 1993;32(7):504–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Aubry A, Chosidow O, Caumes E, Robert J, Cambau E. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med 2002;162(15):1746–52.PubMedCrossRefGoogle Scholar
  13. 13.
    Dailloux M, Hartemann P, Beurey J. Study on the relationship between isolation of mycobacteria and classical microbiological and chemical indicators of water quality in swimming pools. Zentralbl Bakteriol Mikrobiol Hyg B 1980;171(6):473–86.PubMedGoogle Scholar
  14. 14.
    Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium ­marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis 2003;37(3):390–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Mollohan CS, Romer MS. Public health significance of swimming pool granuloma. Am J Public Health Nations Health 1961;51:883–91.PubMedCrossRefGoogle Scholar
  16. 16.
    Feldman M, Long MW, David HL. Mycobacterium marinum: a leisure-time pathogen. J Inf Dis 1974;129(5):618–21.CrossRefGoogle Scholar
  17. 17.
    Jernigan JA, Farr BM. Incubation period and sources of exposure for cutaneous Mycobacterium marinum ­infection: case report and review of the literature. Clin Infect Dis 2000;31(2):439–43.PubMedCrossRefGoogle Scholar
  18. 18.
    Beecham HJ, 3rd, Oldfield EC, 3rd, Lewis DE, Buker JL. Mycobacterium marinum infection from shucking oysters. Lancet 1991;337(8755):1487.PubMedCrossRefGoogle Scholar
  19. 19.
    Tebruegge M, Connell T, Ritz N, Orchard D, Curtis N. Mycobacterium marinum infection following kayaking injury. Int J Infect Dis 2010; 14 Suppl 3:e305-306.PubMedCrossRefGoogle Scholar
  20. 20.
    Cennimo DJ, Agag R, Fleegler E, Lardizabal A, Klein KM, Wenokor C, et al. Mycobacterium marinum Hand Infection in a “Sushi Chef”. Eplasty 2009;9:e43.PubMedGoogle Scholar
  21. 21.
    Lahey T. Invasive Mycobacterium marinum infections. Emerg Infect Dis 2003;9(11):1496–8.PubMedGoogle Scholar
  22. 22.
    Dodiuk-Gad R, Dyachenko P, Ziv M, Shani-Adir A, Oren Y, Mendelovici S, et al. Nontuberculous mycobacterial infections of the skin: A retrospective study of 25 cases. J Am Acad Dermatol 2007;57(3):413–20.PubMedCrossRefGoogle Scholar
  23. 23.
    Ang P, Rattana-Apiromyakij N, Goh CL. Retrospective study of Mycobacterium marinum skin infections. Int J Dermatol 2000;39(5):343–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Walker HH, Shinn MF, Higaki M, Ogata J. Some characteristics of “swimming pool” disease in Hawaii. Hawaii Med J 1962;21:403–9.PubMedGoogle Scholar
  25. 25.
    Runyon EH. Pathogenic mycobacteria. Bibl Tuberc 1965;21:235–87.PubMedGoogle Scholar
  26. 26.
    Runyon EH. Anonymous mycobacteria in pulmonary disease. Med Clin North Am 1959;43(1):273–90.PubMedGoogle Scholar
  27. 27.
    Gao LY, Manoranjan J. Laboratory maintenance of Mycobacterium marinum. Curr Protoc Microbiol 2005;Chapter 10:Unit 10B 1.Google Scholar
  28. 28.
    Kent ML, Watral V, Wu M, Bermudez LE. In vivo and in vitro growth of Mycobacterium marinum at homoeothermic temperatures. FEMS Microbiol Lett 2006;257(1):69–75.PubMedCrossRefGoogle Scholar
  29. 29.
    Clark HF, Shepard CC. Effect of Environmental Temperatures on Infection with Mycobacterium Marinum (Balnei) of Mice and a Number of Poikilothermic Species. J Bacteriol 1963;86:1057–69.PubMedGoogle Scholar
  30. 30.
    Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175(4):367–416.PubMedCrossRefGoogle Scholar
  31. 31.
    Woods GL. Susceptibility testing for mycobacteria. Clin Infect Dis 2000;31(5):1209–15.PubMedCrossRefGoogle Scholar
  32. 32.
    Brown BA, Wallace RJ, Jr., Onyi GO. Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. Antimicrob Agents Chemother 1992;36(9):1987–90.PubMedGoogle Scholar
  33. 33.
    Braback M, Riesbeck K, Forsgren A. Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones. Antimicrob Agents Chemother 2002;46(4):1114–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Stinear TP, Seemann T, Harrison PF, Jenkin GA, Davies JK, Johnson PD, et al. Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res 2008;18(5):729–41.PubMedCrossRefGoogle Scholar
  35. 35.
    Stinear TP, Jenkin GA, Johnson PD, Davies JK. Comparative genetic analysis of Mycobacterium ulcerans and Mycobacterium marinum reveals evidence of recent divergence. J Bacteriol 2000;182(22):6322–30.PubMedCrossRefGoogle Scholar
  36. 36.
    Street ML, Umbert-Millet IJ, Roberts GD, Su WP. Nontuberculous mycobacterial infections of the skin. Report of fourteen cases and review of the literature. J Am Acad Dermatol 1991;24(2 Pt 1):208–15.PubMedCrossRefGoogle Scholar
  37. 37.
    Abbas O, Marrouch N, Kattar MM, Zeynoun S, Kibbi AG, Rached RA, et al. Cutaneous non-tuberculous mycobacterial infections: a clinical and histopathological study of 17 cases from Lebanon. J Eur Acad Dermatol Venereol. 2011;25(1):33–42.Google Scholar
  38. 38.
    Liao CH, Lai CC, Ding LW, Hou SM, Chiu HC, Chang SC, et al. Skin and soft tissue infection caused by non-tuberculous mycobacteria. Int J Tuberc Lung Dis 2007;11(1):96–102.PubMedGoogle Scholar
  39. 39.
    King AJ, Fairley JA, Rasmussen JE. Disseminated cutaneous Mycobacterium marinum infection. Arch Dermatol 1983;119(3):268–70.PubMedCrossRefGoogle Scholar
  40. 40.
    Doedens RA, van der Sar AM, Bitter W, Scholvinck EH. Transmission of Mycobacterium marinum from fish to a very young child. Pediatr Infect Dis J 2008;27(1):81–3.PubMedCrossRefGoogle Scholar
  41. 41.
    Feddersen A, Kunkel J, Jonas D, Engel V, Bhakdi S, Husmann M. Infection of the upper extremity by Mycobacterium marinum in a 3-year-old boy--diagnosis by 16S-rDNA analysis. Infection 1996;24(1):47–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Lacaille F, Blanche S, Bodemer C, Durand C, De Prost Y, Gaillard JL. Persistent Mycobacterium marinum infection in a child with probable visceral involvement. Pediatr Infect Dis J 1990;9(1):58–60.PubMedCrossRefGoogle Scholar
  43. 43.
    Iredell J, Whitby M, Blacklock Z. Mycobacterium marinum infection: epidemiology and presentation in Queensland 1971–1990. Med J Aust 1992;157(9):596–8.PubMedGoogle Scholar
  44. 44.
    Gluckman SJ. Mycobacterium marinum. Clin Dermatol 1995;13(3):273–6.PubMedCrossRefGoogle Scholar
  45. 45.
    Chow SP, Ip FK, Lau JH, Collins RJ, Luk KD, So YC, et al. Mycobacterium marinum infection of the hand and wrist. Results of conservative treatment in twenty-four cases. J Bone Joint Surg Am 1987;69(8):1161–8.PubMedGoogle Scholar
  46. 46.
    Edelstein H. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. Arch Intern Med 1994;154(12):1359–64.PubMedCrossRefGoogle Scholar
  47. 47.
    Casal M, Casal MM. Multicenter study of incidence of Mycobacterium marinum in humans in Spain. Int J Tuberc Lung Dis 2001;5(2):197–9.PubMedGoogle Scholar
  48. 48.
    Parent LJ, Salam MM, Appelbaum PC, Dossett JH. Disseminated Mycobacterium marinum infection and bacteremia in a child with severe combined immunodeficiency. Clin Infect Dis 1995;21(5):1325–7.PubMedCrossRefGoogle Scholar
  49. 49.
    Tchornobay AM, Claudy AL, Perrot JL, Levigne V, Denis M. Fatal disseminated Mycobacterium marinum infection. Int J Dermatol 1992;31(4):286–7.PubMedCrossRefGoogle Scholar
  50. 50.
    Pandian TK, Deziel PJ, Otley CC, Eid AJ, Razonable RR. Mycobacterium marinum infections in transplant recipients: case report and review of the literature. Transpl Infect Dis 2008;10(5):358–63.PubMedCrossRefGoogle Scholar
  51. 51.
    Ramos JM, Garcia-Sepulcre MF, Rodriguez JC, Padilla S, Gutierrez F. Mycobacterium marinum infection complicated by anti-tumour necrosis factor therapy. J Med Microbiol;59(Pt 5):617–21.PubMedCrossRefGoogle Scholar
  52. 52.
    Chopra N, Kirschenbaum AE, Widman D. Mycobacterium marinum tenosynovitis in a patient on etanercept therapy for rheumatoid arthritis. J Clin Rheumatol 2002;8(5):265–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Fallon JC, Patchett S, Gulmann C, Murphy GM. Mycobacterium marinum infection complicating Crohn’s ­disease, treated with infliximab. Clin Exp Dermatol 2008;33(1):43–5.PubMedGoogle Scholar
  54. 54.
    Danko JR, Gilliland WR, Miller RS, Decker CF. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy. Scand J Infect Dis 2009;41(4):252–5.PubMedCrossRefGoogle Scholar
  55. 55.
    Dare JA, Jahan S, Hiatt K, Torralba KD. Reintroduction of etanercept during treatment of cutaneous Mycobacterium marinum infection in a patient with ankylosing spondylitis. Arthritis Rheum 2009;61(5):583–6.PubMedCrossRefGoogle Scholar
  56. 56.
    Rallis E, Koumantaki-Mathioudaki E, Frangoulis E, Chatziolou E, Katsambas A. Severe sporotrichoid fish tank granuloma following infliximab therapy. Am J Clin Dermatol 2007;8(6):385–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 2009;15(10):1556–61.PubMedGoogle Scholar
  58. 58.
    Swart RM, van Ingen J, van Soolingen D, Slingerland R, Hendriks WD, den Hollander JG. Nontuberculous mycobacteria infection and tumor necrosis factor-alpha antagonists. Emerg Infect Dis 2009;15(10):1700–1.PubMedGoogle Scholar
  59. 59.
    Harris J, Keane J. How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin Exp Immunol 2010;161(1):1–9.PubMedGoogle Scholar
  60. 60.
    Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345(15):1098–104.PubMedCrossRefGoogle Scholar
  61. 61.
    Mohan AK, Cote TR, Block JA, Manadan AM, Siegel JN, Braun MM. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis 2004;39(3):295–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Streit M, Bohlen LM, Hunziker T, Zimmerli S, Tscharner GG, Nievergelt H, et al. Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient. Eur J Dermatol 2006;16(1):79–83.PubMedGoogle Scholar
  63. 63.
    Travis WD, Travis LB, Roberts GD, Su DW, Weiland LW. The histopathologic spectrum in Mycobacterium ­marinum infection. Arch Pathol Lab Med 1985;109(12):1109–13.PubMedGoogle Scholar
  64. 64.
    Middlebrook G, Cohn ML. Bacteriology of tuberculosis: laboratory methods. Am J Public Health Nations Health 1958;48(7):844–53.PubMedCrossRefGoogle Scholar
  65. 65.
    Ringuet H, Akoua-Koffi C, Honore S, Varnerot A, Vincent V, Berche P, et al. hsp65 sequencing for identification of rapidly growing mycobacteria. J Clin Microbiol 1999;37(3):852–7.PubMedGoogle Scholar
  66. 66.
    Devallois A, Goh KS, Rastogi N. Rapid identification of mycobacteria to species level by PCR-restriction ­fragment length polymorphism analysis of the hsp65 gene and proposition of an algorithm to differentiate 34 mycobacterial species. J Clin Microbiol 1997;35(11):2969–73.PubMedGoogle Scholar
  67. 67.
    Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of mycobacteria to the ­species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993;31(2):175–8.PubMedGoogle Scholar
  68. 68.
    Talaat AM, Reimschuessel R, Trucksis M. Identification of mycobacteria infecting fish to the species level using polymerase chain reaction and restriction enzyme analysis. Vet Microbiol 1997;58(2–4):229–37.PubMedCrossRefGoogle Scholar
  69. 69.
    Kirschner P, Springer B, Vogel U, Meier A, Wrede A, Kiekenbeck M, et al. Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. J Clin Microbiol 1993;31(11):2882–9.PubMedGoogle Scholar
  70. 70.
    Cai L, Chen X, Zhao T, Ding BC, Zhang JZ. Identification of Mycobacterium marinum 65 kD heat shock protein gene by polymerase chain reaction restriction analysis from lesions of swimming pool granuloma. Chin Med J (Engl) 2006;119(1):43–8.Google Scholar
  71. 71.
    Witteck A, Ohlschlegel C, Boggian K. Delayed diagnosis of atypical mycobacterial skin and soft tissue infections in non-immunocompromized hosts. Scand J Infect Dis 2008;40(11–12):877–80.PubMedCrossRefGoogle Scholar
  72. 72.
    Sanal HT, Zor F, Kocaoglu M, Bulakbasi N. Atypical mycobacterial tenosynovitis and bursitis of the wrist. Diagn Interv Radiol 2009;15(4):266–8.PubMedGoogle Scholar
  73. 73.
    van Coppenraet LS, Smit VT, Templeton KE, Claas EC, Kuijper EJ. Application of real-time PCR to recognize atypical mycobacteria in archival skin biopsies: high prevalence of Mycobacterium haemophilum. Diagn Mol Pathol 2007;16(2):81–6.PubMedCrossRefGoogle Scholar
  74. 74.
    Jolly HW, Jr., Seabury JH. Infections with Myocbacterium marinum. Arch Dermatol 1972;106(1):32–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Arend SM, van Meijgaarden KE, de Boer K, de Palou EC, van Soolingen D, Ottenhoff TH, et al. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis 2002;186(12):1797–807.Google Scholar
  76. 76.
    Tan T, Lee WL, Alexander DC, Grinstein S, Liu J. The ESAT-6/CFP-10 secretion system of Mycobacterium marinum modulates phagosome maturation. Cell Microbiol 2006;8(9):1417–29.PubMedCrossRefGoogle Scholar
  77. 77.
    Gao LY, Guo S, McLaughlin B, Morisaki H, Engel JN, Brown EJ. A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. Mol Microbiol 2004;53(6):1677–93.PubMedCrossRefGoogle Scholar
  78. 78.
    Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Okimoto N, et al. Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis 2009;13(11):1422–6.PubMedGoogle Scholar
  79. 79.
    Perez-Jorge EV, Burdette SD. Chronic ulceration from Mycobacterium marinum infection and the diagnostic value of T-cell interferon-gamma release assays. Mol Diagn Ther 2010;14(2):119–22.PubMedGoogle Scholar
  80. 80.
    Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Oka M. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin Infect Dis 2006;43(12):1540–6.PubMedCrossRefGoogle Scholar
  81. 81.
    Noonburg GE. Management of extremity trauma and related infections occurring in the aquatic environment. J Am Acad Orthop Surg 2005;13(4):243–53.PubMedGoogle Scholar
  82. 82.
    Howard RJ, Bennett NT. Infections caused by halophilic marine Vibrio bacteria. Ann Surg 1993;217(5):525–30PubMedCrossRefGoogle Scholar
  83. 83.
    Dechet AM, Yu PA, Koram N, Painter J. Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997–2006. Clin Infect Dis 2008;46(7):970–6.PubMedCrossRefGoogle Scholar
  84. 84.
    Kumamoto KS, Vukich DJ. Clinical infections of Vibrio vulnificus: a case report and review of the literature. J Emerg Med 1998;16(1):61–6.PubMedCrossRefGoogle Scholar
  85. 85.
    Tacket CO, Brenner F, Blake PA. Clinical features and an epidemiological study of Vibrio vulnificus infections. J Infect Dis 1984;149(4):558–61.PubMedCrossRefGoogle Scholar
  86. 86.
    Gold WL, Salit IE. Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review. Clin Infect Dis 1993;16(1):69–74.PubMedCrossRefGoogle Scholar
  87. 87.
    Kelly KA, Koehler JM, Ashdown LR. Spectrum of extraintestinal disease due to Aeromonas species in tropical Queensland, Australia. Clin Infect Dis 1993;16(4):574–9.PubMedCrossRefGoogle Scholar
  88. 88.
    Tsai YH, Hsu RW, Huang TJ, Hsu WH, Huang KC, Li YY, et al. Necrotizing soft-tissue infections and sepsis caused by Vibrio vulnificus compared with those caused by Aeromonas species. J Bone Joint Surg Am 2007;89(3):631–6.PubMedCrossRefGoogle Scholar
  89. 89.
    Brooke CJ, Riley TV. Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. J Med Microbiol 1999;48(9):789–99.PubMedCrossRefGoogle Scholar
  90. 90.
    King PF. Erysipeloid Survey of 115 cases. Lancet 1946;248(6416):196–8.CrossRefGoogle Scholar
  91. 91.
    Reboli AC, Farrar WE. Erysipelothrix rhusiopathiae: an occupational pathogen. Clin Microbiol Rev 1989;2(4):354–9.PubMedGoogle Scholar
  92. 92.
    Dorronsoro I, Sarasqueta R, Gonzalez AI, Gallego M. [Cutaneous infections by Mycobacterium marinum. Description of 3 cases and review of the literature]. Enferm Infecc Microbiol Clin 1997;15(2):82–4.PubMedGoogle Scholar
  93. 93.
    Lee MW, Brenan J. Mycobacterium marinum: chronic and extensive infections of the lower limbs in south Pacific islanders. Australas J Dermatol 1998;39(3):173–6.PubMedCrossRefGoogle Scholar
  94. 94.
    Kern W, Vanek E, Jungbluth H. [Fish breeder granuloma: infection caused by Mycobacterium marinum and other atypical mycobacteria in the human. Analysis of 8 cases and review of the literature]. Med Klin (Munich) 1989;84(12):578–83.Google Scholar
  95. 95.
    Huminer D, Pitlik SD, Block C, Kaufman L, Amit S, Rosenfeld JB. Aquarium-borne Mycobacterium marinum skin infection. Report of a case and review of the literature. Arch Dermatol 1986;122(6):698–703.PubMedCrossRefGoogle Scholar
  96. 96.
    Harris DM, Keating MR. Mycobacterium marinum: current recommended pharmacologic therapy. J Hand Surg Am 2009;34(9):1734–5.PubMedCrossRefGoogle Scholar
  97. 97.
    Cummins DL, Delacerda D, Tausk FA. Mycobacterium marinum with different responses to second-generation tetracyclines. Int J Dermatol 2005;44(6):518–20.PubMedCrossRefGoogle Scholar
  98. 98.
    Hurst LC, Amadio PC, Badalamente MA, Ellstein JL, Dattwyler RJ. Mycobacterium marinum infections of the hand. J Hand Surg Am 1987;12(3):428–35.PubMedGoogle Scholar
  99. 99.
    Molicotti P, Ortu S, Bua A, Cannas S, Sechi LA, Zanetti S. In vitro efficacy of Linezolid on clinical strains of Mycobacterium tuberculosis and other mycobacteria. New Microbiol 2006;29(4):275–80.PubMedGoogle Scholar
  100. 100.
    Brown-Elliott BA, Crist CJ, Mann LB, Wilson RW, Wallace RJ, Jr. In vitro activity of linezolid against slowly growing nontuberculous mycobacteria. Antimicrob Agents Chemother 2003;47(5):1736–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of PaediatricsThe University of MelbourneParkvilleAustralia
  2. 2.Department of General MedicineInfectious Diseases UnitParkvilleAustralia
  3. 3.Murdoch Childrens Research InstituteParkvilleAustralia
  4. 4.Royal Children’s Hospital MelbourneParkvilleAustralia

Personalised recommendations